LSL Pharma Group Grants 960,000 Stock Options to Directors and Employees
I'm PortAI, I can summarize articles.
LSL Pharma Group Inc. has granted 960,000 stock options to its non-executive directors, executives, and employees as part of their compensation. The options have an exercise price of CAD $0.52 per share and a ten-year term. Non-executive directors’ options vest immediately, while those for executives and employees will vest over three years, subject to a four-month hold period.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments